Healthcare Development & Innovation Group (HDIG)’s Post

🚀 AI in Life Sciences: A Nordic Perspective on Startups and Investments 🚀 The Nordic region is growing as a hotspot for AI-driven innovations in the life sciences sector. With a strong emphasis on collaboration, cutting-edge research, and strategic investments, the Nordics are poised to make strides in health tech. 🔬 Startups Leading the Charge: Notable AI startups in the Nordics are revolutionizing digital pathology, drug discovery, and personalized medicine through advanced AI algorithms. The region’s robust ecosystem supports innovation, enabling startups to thrive and scale their solutions globally (https://lnkd.in/dAqZBG8k). 💰 Investment Landscape: Venture capital is going into Nordic AI startups at an increasing rate. Despite a global slowdown in dealmaking, Nordic life sciences startups attracted significant investments, with €1.8 billion raised in the first half of 2023 alone. Key investors such as LSI Beta & LSI Gamma AB are actively backing these startups in early phases, highlighting the sector's potential for substantial returns (https://lnkd.in/dFs3JX7n). 🌟 Bright Future for VC Fundraising: Optimism is getting higher for VC fundraising in the Nordics in 2024, driven by lower interest rates and a strong demand for innovative investment opportunities. This favorable environment is set to fuel further growth and development in the AI and life sciences sectors, positioning the region as a leader in health tech advancements (https://lnkd.in/dAqZBG8k). 🌐 Collaborative Strengths: The Nordic countries are leveraging their collective strengths, including shared values, trust in public institutions, and a wealth of collected data. This collaboration extends across academia, industry, and government, fostering an environment where AI can be responsibly developed and implemented to enhance public services and healthcare outcomes (https://lnkd.in/dN8_6uPj). As we look to the future, the synergy between AI and life sciences in the Nordics promises to deliver groundbreaking advancements that will improve healthcare delivery and patient outcomes on a global scale. Stay tuned for more updates on this exciting journey! #AI #LifeSciences #HealthTech #Startups #Investments #Nordics #Innovation #VentureCapital #Collaboration #DigitalHealth

US digital health innovators, are you ready to propel your start-up to new heights? Now's your chance to make it happen!💡 Secure your spot in the Merck Digital Sciences Studio #accelerator program and unlock $150,000 through a SAFE agreement! Act now before the extended deadline of May 31st, 2024, and take your digital health innovation to the next level. Don't miss out on this great opportunity! https://bit.ly/3xXepqo The MDS Studio is a collaboration between Merck and the New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology corporation, with investments from the Merck Global #HealthInnovation Fund, Northpond Ventures, and McKesson Ventures. 💰 MDS Studio Offers: ✔️ Up to $150,000 investment via a SAFE;  ✔️ $150,000 in Azure compute credits; ✔️ Access to Microsoft's Founders Hub resources; ✔️ 10-month hands-on #accelerator program providing #mentorship, #coaching, training, support, #community, and #investment to enable the next generation of innovative technologies for #drug #discovery and development; ✔️ Opportunities to #showcase your #technologies in #collaboration with discovery and clinical scientists at Merck. ✔️ Technology support is provided by Microsoft for Startups. 💥 Application Deadline: May 31st, 2024 💡 Therapeutic areas of interest:  #Cardiology, #Immunology, #InfectiousDiseases, #Metabolism & #Diabetes, #Oncology, #Respirology, #Cardiovascular. MDS Studio isn't just a program, it's a vibrant community of support & collaboration. Workshops aren't just about lectures - they're about hands-on exploration, dynamic discussions, and immediate implementation of startup-building best practices. 📌 Ready to elevate your #startup? Learn more and Apply here: https://bit.ly/3xXepqo #digitalhealth #partnershipopportunity #startupswanted #innovation #Pharma #startups #digitalinnovators #accelerationprogram

💥 LAST 2 DAYS to apply for the Merck Digital Sciences Studio #accelerator program that provides $150,000 through a SAFE agreement and $150,000 in Azure compute credits for digital health innovations. 💰 MDS Studio Offers: ✔️ Up to $150,000 investment via a SAFE; ✔️ $150,000 in Azure compute credits; ✔️ Access to Microsoft's Founders Hub resources; ✔️ 10-month hands-on #accelerator program providing #mentorship, #coaching, training, support, #community, and #investment to enable the next generation of innovative technologies for #drug #discovery and development; ✔️ Opportunities to #showcase your #technologies in #collaboration with discovery and clinical scientists at Merck. ✔️ Technology support is provided by Microsoft for Startups. Don't miss out on this great opportunity! https://bit.ly/3xXepqo

🇨🇦 Vancouver: A Thriving Hub of Tech Innovation! 🏔️ 🔍 Vancouver is not just known for its breathtaking landscapes — it's a center for tech innovation. Our latest article explores the top 10 emerging tech companies in Vancouver that are making significant strides in various industries: 📌 Top Companies: - Avivo Biomedical: Leading healthcare innovation with blood antigen conversion technology. - Artemis: Transforming data analytics with AI-powered data engineering solutions. - Scope Carbon: Utilizing AI to drive data processing and analysis across multiple sectors. - …and more! 🌍 Vancouver's tech ecosystem hosts over 1,600 companies, each with an average workforce of 10 employees. Key sectors include healthcare, information technology, edtech, and maritime. 💡 Supported by key investors like entrepreneurship@ubc, VentureLabs, and Creative Destruction Lab, these companies receive essential funding across all stages — from Seed, Accelerator, to Early-Stage VC. 🔗 Explore the full article: https://lnkd.in/djnAghVJ #Tech #Innovation #VancouverStartups #StartupEcosystem #TopStartups

💥 Extended Deadline: May 31st, 2024 for the Merck Digital Sciences Studio #accelerator program that provides $150,000 through a SAFE agreement and $150,000 in Azure compute credits for digital health innovations. 💰 MDS Studio Offers: ✔️ Up to $150,000 investment via a SAFE; ✔️ $150,000 in Azure compute credits; ✔️ Access to Microsoft's Founders Hub resources; ✔️ 10-month hands-on #accelerator program providing #mentorship, #coaching, training, support, #community, and #investment to enable the next generation of innovative technologies for #drug #discovery and development; ✔️ Opportunities to #showcase your #technologies in #collaboration with discovery and clinical scientists at Merck. ✔️ Technology support is provided by Microsoft for Startups. Don't miss out on this great opportunity! https://bit.ly/3xXepqo

🤔 Interesting 2024 predictions by The Bessemer Venture Partners for healthcare and life sciences. They highlight a shift due to reduced venture investment, with a focus on #AI, #data #privacy, and longevity medicine. They foresee a pull back of what they call "tourist investors" from #healthtech, increased partnerships between existing #healthcare companies and startups, and growth in #opensource AI models. Lots more in the report! Check it out! https://lnkd.in/gJC_BFe7

It was fascinating to get a glimpse into the world of a pioneering leader and visionary - Prof. Yitzhak Kreiss, CEO of Sheba, who is leading an adaptive strategic change and practically transforming medical centers into economic growth engines by embedding DNA for the development of transformation, innovation, and technological entrepreneurship, while deeply connecting with the international high-tech industry ecosystem. Under his leadership and that of Prof. Eyal Zimlichman, CEO of ARC, Sheba has become a global impact on healthcare, working on investments and integrating startups into professional activities in hospitals worldwide, establishing a center for integrating generative artificial intelligence in medicine, developing the future hospital in the Negev, and more. On Thursday, I attended the annual international conference of ARC Innovation , the innovation and entrepreneurship center of Sheba Medical Center, which was filled with moments of hope, innovation, creativity, and Israeli pride in the world of Health-Tech. The data presented at the conference gives reason for optimism regarding the leading engine of the economy. Israeli high-tech proves resilience. The CEO of Israel Innovation Authority and the CEO of Startup Nation Central noted that despite Israel being at war, we experienced only a slight decrease in investments, and Israel still leads in R&D investment as a percentage of GDP, standing at 6.1%. The number of startups in the Health Tech field is particularly high, but the investment rate is lower compared to other investment areas due to the high risk. The conference leaders called for increased investments in Health-Tech companies because the ROI on successful companies is significantly higher. Congratulations to the management of Sheba Medical Center and the ARC team for their outstanding achievements and for an impressive conference with significant international presence from the worlds of Healthcare, Venture Capital, High-Tech, and Academia.

Mayo Clinic and Arizona State University Accelerator Announce Latest Cohort of MedTech Startups Focused on AI Mayo Clinic and Arizona State University have announced their latest cohort of healthcare startups under their Arizona-based MedTech Accelerator. Demonstrating the ongoing changes in the healthcare industry, the accelerator highlights the pivotal role that AI will play in medical innovation. This cohort of startups will be the 5th group to proceed through the program, which provides comprehensive resources and mentorship for successful healthcare entrepreneurship. After completing the program, participants will continue to receive support and collaboration opportunities from the Mayo Clinic and ASU. As creators of OxyDial, our own MedTech startup focused on improving testing and care for patients with blood diseases like Sickle Cell, the GlenFlow Ventures team is thrilled with the continued progress in the AI and technology-oriented healthcare space. We're eager to see what innovations Mindsigns Health™, Scaled Insights, MiiCare, and the other members of this cohort will bring to the industry. Discover more on this news: https://lnkd.in/esmdV3Nm #mayoclinic #arizonastateuniversity #accelerator #medtech #startups #ai #healthcare #innovation #entrepreneurship #oxydial #glenflowventures #mindsignshealth #scaledinsights #miicare

🌟 𝐇𝐞𝐚𝐥𝐭𝐡 & 𝐁𝐢𝐨 𝐓𝐞𝐜𝐡 𝐅𝐨𝐮𝐧𝐝𝐞𝐫𝐬 𝐦𝐞𝐞𝐭 𝐢𝐧 𝐄𝐬𝐬𝐞𝐧 (3 days left to apply)🌟 Emerging Technologies in Medicine (ETIM) 2024 beckons! If your startup is innovating at the intersection of AI and healthcare, here’s your platform to shine. The Startup Corner, presented by Techstars, #UniversityMedicineEssen, Place Beyond Bytes, and the Universität Duisburg-Essen, is an integral part of this year's ETIM, focusing on "AI at the Point of Care." 𝘞𝘩𝘺 𝘠𝘰𝘶 𝘚𝘩𝘰𝘶𝘭𝘥 𝘈𝘱𝘱𝘭𝘺: - Showcase your technology with a 5-minute pitch to an audience of AI and healthcare aficionados. - Receive invaluable live feedback from investors, clinicians, and tech experts. - Enjoy complimentary access to the conference, opening doors to unparalleled networking opportunities. 𝘞𝘦'𝘳𝘦 𝘰𝘯 𝘵𝘩𝘦 𝘏𝘶𝘯𝘵 𝘧𝘰𝘳: - Startups less than three years old, with a vision to disrupt healthcare diagnostics or therapeutics. - Teams of up to 25 members eager to present their solutions to critical challenges in health tech or biotech. 𝘈𝘱𝘱𝘭𝘪𝘤𝘢𝘵𝘪𝘰𝘯 𝘌𝘴𝘴𝘦𝘯𝘵𝘪𝘢𝘭𝘴: - Craft three slides detailing your team's composition, your visionary goals, and your innovative business model. Don't forget a cover slide with your contact details. 𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭 𝐃𝐚𝐭𝐞𝐬: Application Deadline: February 29th Acceptance Notification: March 6th Pitch Day: March 16th As a bonus, we’ll cover travel and accommodation for one founder from each selected startup. This is more than an event; it’s a launching pad for your startup, supported by leaders in innovation and healthcare education. Ready to make your mark? Apply now and join us in driving the future of medicine. #HealthTech #Biotech #Startups #ETIM2024

Seattle Health Care Tech Company PreemptiveAI Launches from Stealth https://lnkd.in/ggqDmpbX Seattle-based health tech startup, and Allen Institute for AI spinout, PreemptiveAI raised $6.4M in funding and announced a partnership with Duke University to test its predictive healthcare technology. The platform analyzes biomedical signals from wearables to provide real-time diagnoses, such as predicting heart attacks or detecting undiagnosed cancer. The startup aims to revolutionize healthcare delivery for providers, pharmaceutical companies, and payers. “PreemptiveAI represents a monumental leap forward in our pursuit of transformative healthcare. Their technology is the catalyst we’ve needed to shift paradigms,” said Lana Wahid, medical director of Duke’s early-phase research unit. Founded as a spinout of Seattle’s Allen Institute for AI, PreemptiveAI plans further commercial launches in 2024. The post Seattle Health Care Tech Company PreemptiveAI Launches from Stealth appeared first on Life Science Washington . Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks